[ACRS] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
03-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 16.91%
YoY- -0.57%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 1,449 983 1,628 684 0 0 0 -
PBT -10,659 -23,138 -32,740 -18,192 -10,694 -10,633 -2,657 26.02%
Tax -591 32,733 0 0 0 -32 0 -
NP -10,659 -55,319 -32,740 -18,192 -10,694 -10,633 -2,657 26.02%
Tax Rate - - - - - - - -
Total Cost 12,108 56,302 34,368 18,876 10,694 10,633 2,657 28.73%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -735.61 -5,627.57 -2,011.06 -2,659.65 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.25 -1.34 -1.06 -0.63 -0.50 -0.55 -0.25 0.00%
EPS Diluted -0.25 -1.34 -1.06 -0.63 -0.50 -0.55 -0.25 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.